Leo Cancer Care secures $65M to advance upright radiotherapy system as company preps for IPO

Cancer therapy spinout Myricx Bio agrees to US$1.5B acquisition by Novartis

Myricx Bio, a cancer therapy spinout from the Francis Crick Institute and Imperial College London, has agreed to be acquired by Novartis in

Cancer Treatment Costs Jump 37.7% in Five Years, Boosting Long-Term Cancer Insurance

Astral Systems raises £23m Series A to scale multi-state nuclear fusion technology for medical radioisotopes

Bristol-based deep tech firm Astral Systems has raised £23m in Series A funding led by Mercia Ventures. The company has developed and commer

CRIS Contra el Cáncer financia una nueva estrategia de terapias dirigidas frente al cáncer de ovario

Cadence Raises $100M Series C for AI-Powered Chronic Disease Management Platform

Cadence, a New York-based health tech startup, raised $100 million in Series C funding (led by Spark Capital, totaling $241M raised) to scal

A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction.